AwardTape · Defense awards · Research and development · Science and technology R&D · HT942523D0011
HT942523D0011: $0 IDIQ contract to Eitr Biologics, Inc
Eitr Biologics, Inc holds an IDIQ contract from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $11.5M. Latest action Mar 9, 2026.
Novel nanotherapeutics for combatting pneumonic plague
| PIID | HT942523D0011 |
|---|---|
| Type | IDIQ contract |
| Company | Eitr Biologics, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Research and development · Science and technology R&D |
| PSC | AJ11 GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $11.5M |
| Base date | Aug 15, 2023 |
| Latest action | Mar 9, 2026 |
| End date | n/a |
| Actions since Oct 2023 | 3 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| HT942524F0269 delivery order | Eitr Biologics, Inc | $1.9M | Novel nanotherapeutics | Defense Health Agency | Science and technology R&D | Jul 2, 2025 DoD 90d |
| HT942526FE010 delivery order | Eitr Biologics, Inc | $927K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | Jan 28, 2026 DoD 90d |
| HT942524F0127 delivery order | Eitr Biologics, Inc | $500K | Develop a novel odin therapeutic medical countermeasure capable of protecting against pneumonic unencapsulated y. pestis. | Defense Health Agency | Science and technology R&D | May 16, 2024 DoD 90d |
| HT942525F0221 delivery order | Eitr Biologics, Inc | $300K | Novel nanotherapeutics | Defense Health Agency | Science and technology R&D | May 19, 2025 DoD 90d |
| HT942626FE033 delivery order | Eitr Biologics, Inc | $270K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | Mar 30, 2026 DoD 90d |
| HT942626FE055 delivery order | Eitr Biologics, Inc | $100K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | May 21, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial